Association of serum levels of osteopontin and osteoprotegerin with adverse outcomes after endovascular revascularisation in peripheral artery disease

BACKGROUND: Osteoprotegerin (OPG) and osteopontin (OPN) are vascular calcification inhibitors with a known role in the atherosclerotic and inflammatory process. We investigated their relationship with adverse outcomes (restenosis/adverse cardiovascular events) after endovascular revascularisation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadoglou, Nikolaos P. E., Kapetanios, Dimitrios, Korakas, Emmanouil, Valsami, Georgia, Tentolouris, Nikolaos, Papanas, Nikolaos, Lambadiari, Vaia, Karkos, Christos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438128/
https://www.ncbi.nlm.nih.gov/pubmed/36050687
http://dx.doi.org/10.1186/s12933-022-01605-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438128/
https://www.ncbi.nlm.nih.gov/pubmed/36050687
http://dx.doi.org/10.1186/s12933-022-01605-6

Ejemplares similares